Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
ReutersOct 21, 2025 12:37 PM
Oct 21 (Reuters) - Fortress Biotech Inc FBIO.O:
FORTRESS BIOTECH AND SUBSIDIARY URICA THERAPEUTICS ANNOUNCE FIRST PATIENTS DOSED IN CRYSTALYS THERAPEUTICS’ GLOBAL PHASE 3 TRIALS OF DOTINURAD FOR THE TREATMENT OF GOUT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Tesla Q3 Earnings Preview: Record Deliveries “Burn Out,” Growth Path Filled With Uncertainty
TradingKey - Riding on improved market sentiment and Elon Musk’s renewed focus on his role as Tesla CEO, Tesla’s stock has rebounded over 85% in the past six months — the strongest recovery among the Magnificent Seven. Tesla is set to report its Q3 2025 earnings after market close on October 22TradingKey
10 hours ago
"No Kings" Protests: If It Persists, Sell U.S. Stocks and Buy Gold
TradingKey - On the morning of Saturday, 18 October, large-scale demonstrations broke out in multiple U.S. cities, where people protested against Trump's policies. Rallies were held in cities including New York, Washington, D.C., Chicago, Miami, and Los Angeles.TradingKey
19 hours ago
Netflix Q3 Earnings Preview: Double Growth in Revenue and Profit Expected Amid Wall Street's Universal Optimism
TradingKey - Streaming giant Netflix is set to release its Q3 2025 financial results after U.S. market close on Tuesday, October 21. According to data provided by LSEG, analysts expect Netflix's third-quarter revenue to grow 17% year-over-year to $11.51 billion, with earnings per share projected...TradingKey
Mon, Oct 20
-cf2d64246507436b9c1b84e5d824bbdb.jpg)
Can Zcash (ZEC) Sustain Its Rally? What’s Next for Its Price Trajectory?
Launched in 2016, Zcash (ZEC) is a cryptocurrency focused on privacy protection. Its key innovation lies in selective privacy, allowing users to choose between transparent and shielded transactions.TradingKey
Sat, Oct 18
TSMC Q3 Earnings Preview: Record Revenue Is a Lock, but an Upgraded Outlook Could Be the Real Catalyst
TradingKey - Global semiconductor foundry leader Taiwan Semiconductor Manufacturing Company (TSMC, TSM) will report its Q3 2025 earnings on Thursday, October 16, before U.S. markets open. With record-breaking revenue already confirmed by monthly reports, analysts expect record profits andTradingKey
Tue, Oct 14
-f8d64d3844fb416dac43dbc6861db8ff.jpg)
